338. Pierre F, Maurice P, Gilles R, et al, editors. A randomized phase III trial of sequential chemo-radiotherapy versus concurrent chemoradiotherapy in locally advanced non-small cell lung cancer (NSCLC) (GLOT-GFPC NPC 95-01study) [abstract 1246]. ASCO; 2001.
339. Zatloukal PV, Petruzelka L, Zemanova M, et al, editors. Concurrent versus sequential radio-chemotherapy with vinorelbine plus cisplatin (V-P) in locally advanced non-small cell lung cancer. A randomized phase II study [abstract 1159]. ASCO; 2002.
340. NCCN. NCCN Practice Guideline in Oncology, Non-Small Cell Lung Cancer. 2006 [cited 2006]; Available from: http://www.nccn.org/.
341. NICE. Diagnosis and treatment of lung cancer. National Collaborating Centre for Acute Care. London; 2005.
342. Vokes EE, Herndon J, Kelley MJ, Watson D, Cicchetti MC, Green MR, editors. Induction chemotherapy followed by concomitant chemoradiotherapy (CT/XRT) versus CT/XRT alone for regionally advanced unresectable non-small cell lung cancer (NSCLC): initial analysis of a randomized phase III trial. ASCO; 2004; New Orleans, LA.
343. Hanna N, Neubauer M, Yiannoutsos C, et al. Phase III study of cisplatin, etoposide, and concurrent chest radiation with or without consolidation docetxzel in patients with inoperable stage III non-small-cell lung cancer: the Hoosier Oncology Group and U.S. Oncology. J Clin Oncol 2008;26: 5755-60.
344. Vokes EE, Herndon JE 2nd, Crawford J, Leopold KA, Perry MC, Miller AA, et al. Randomized phase II study of cisplatin with gemcitabine or paclitaxel or vinorelbine as induction chemotherapy followed by concomitant chemoradiotherapy for stage IIIB non-small-cell lung cancer: cancer and leukemia group B study 9431. J Clin Oncol 2002;20:4191-8.
345. KASLC. Web based Case Report Forms and Randomization System. 2005; Available from: http://lung.healthroad.co.kr/.
346. Socinski MA, Blackstock AW, Bogart JA, et al. Randomized phase II trial of induction chemotherapy followed by concurrent chemotherapy and dose-escalated thoracic conformal radiotherapy (74 Gy) in stage III non-small-cell lung cancer: CALGB 30105. J Clin Oncol 2008;26:2457-63.
347. Bradley JD, Moughan J, Graham MV, et al. A phase I/II radiation dose escalation study with concurrent chemotherapy for patients with inoperable stages I to III non-small-cell lung cancer: phase I results of RTOG 0117. Int J Radiat Oncol Biol phys 2010;77:367-72.
348. Schild SE, McGinnis WL, Graham D, et al. Results of a Phase I trial of concurrent chemotherapy and escalating doses of radiation for unresectable non-small cell lung cancer. Int J Radiat Oncol Biol Phys 2006;65:1106-11.
349. Saunders M, Dische S, Barrett A, Harvey A, Gibson D, Parmar M. Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multicentre trial. CHART Steering Committee. Lancet 1997;350:161-5.
350. NCCN. NCCN Practice Guideline in Oncology, Non-Small Cell Lung Cancer 2010.
351. Comella P, Filippelli G, De Cataldis G, Massidda B, Frasci G, Maiorino L, et al. Efficacy of the combination of cisplatin with either gemcitabine and vinorelbine or gemcitabine and paclitaxel in the treatment of locally advanced or metastatic non-small-cell lung cancer: a phase III randomised trial of the Southern Italy Cooperative Oncology Group (SICOG 0101). Ann Oncol 2007;18:324-30.
352. Fossella F, Pereira JR, von Pawel J, Pluzanska A, Gorbounova V, Kaukel E, et al. Randomized,

<PAGE>126
폐암 진료지침